Centivax has 4 close competitors: Alloy Therapeutics, Biosplice Therapeutics, Colossal Biosciences.
Sector, valuation and status for each competitor.
A private valuation and a public market cap share one column; each row names its basis and date.
Centivax
Biosplice Therapeutics
Colossal Biosciences
Formation BioVaccine development company focused on infectious disease vaccines
Centivax competes with 4 companies here: Alloy Therapeutics, Biosplice Therapeutics, Colossal Biosciences, Formation Bio.
No. Centivax is a private company; its shares do not trade on a public exchange.
Lead investors for each round are in the funding timeline.
The closest biotechnology - vaccines peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.